T

Thymmune Therapeutics

9 employees

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$7M

from 2 investors over 2 rounds

T

Thymmune Therapeutics raised $7M on March 1, 2023

Investors: Pillar VC and NYBC Ventures

FAQ